Thomas Bures
2022
In 2022, Thomas Bures earned a total compensation of $944.2K as Senior Vice President and Chief Financial Officer at Pieris Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $106,708 |
|---|---|
| Option Awards | $444,183 |
| Salary | $381,100 |
| Other | $12,200 |
| Total | $944,191 |
Bures received $444.2K in option awards, accounting for 47% of the total pay in 2022.
Bures also received $106.7K in non-equity incentive plan, $381.1K in salary and $12.2K in other compensation.
Rankings
In 2022, Thomas Bures' compensation ranked 3,153rd out of 5,736 executives tracked by ExecPay. In other words, Bures earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,153 out of 5,736 | 45th |
Division Manufacturing | 1,773 out of 3,125 | 43rd |
Major group Chemicals And Allied Products | 837 out of 1,416 | 41st |
Industry group Drugs | 781 out of 1,317 | 41st |
Industry Pharmaceutical Preparations | 569 out of 963 | 41st |
Source: SEC filing on November 6, 2024.
Bures' colleagues
We found one more compensation record of an executive who worked with Thomas Bures at Pieris Pharmaceuticals in 2022.
2022
Stephen Yoder
Pieris Pharmaceuticals